Abstract
The 94 kDa protein (MED94) of: B. thuringiensis subsp. medellin has been recognized as tha main toxicity factor of this bacterium to mosquito larvae. From a genomic library evaluated by inmunoblot with polyclonal antobodies raised against MED94, it was possible to identify, clone, and sequence the gene encoding this endotoxin. This report describes the subcloning procedure of this gene using the phagemid pBlueScript SK(-) as a donor of a 3.3 kpb fragment flanqued EcoRI-HindIII (RH3). Two shuttle vectors (pBU4 y pMK3), harbouring replication origins compatible with B. thuringiensis, were the receptors of the gene. These plasmids differ in source, copy number, selection marker, and structural-segregational stability. The transforming procedure of B. thuringiensis subsp. israelensis through electroporation with each construct, gave rise to recombinant strains of B. thuringiensis subsp. israelensis 4Q2-81 (acrystalliferous strain) and B. thuringiensis subsp. israelensis 1884 (H14 serotype, used in commercial formulations), this strain expressed the introduced gene, according to Western blot and toxicity bioassays results. Recombinants were tested by means of Southern blot experiments to detected the presence and integrity of the introduced gene, it was also analized the expression of native δ-endotoxins of B. thuringiensis subsp. israelensis 1884. The half letal concentration (LC50) of crystal protein was estimated bay Probit analysis, as a measure of the toxicity against third instar larvae of Aedes aegypti exposed to samples of the purified parasporal crystals, and compared to the toxicity produced by native strains.
Get full access to this article
View all access options for this article.
